Chapter 7-- IS THE MANUFACTURED HOCL IDENTICAL TO THE ENDOGENOUS HOCL? -- Pioneer of HOCL Science with Jeffrey F. Williams
This is a really good point, because I think there isn't really another equivalent. Industry can make HOCl in a number of ways, but mostly by using salt water and electrical energy. We can make a substance that is the exact equivalent of what you make in your white blood cells. So, we can make a natural human body product and we can make it on a scale that nothing else matches.
When you think about human body natural products that are a part of the pharmaceutical industry's offerings, you think of things like insulin, right?
We can make an insulin that pretty much mimics exactly what our bodies make and we can use it therapeutically or in preventive ways, but you can't make it by the hundreds of kilograms, you can't make it on a scale that enables us to think realistically of tons of HOCl being used regularly all over the world for improvement in oral health.
That's a pretty remarkable statement to be able to make, that this natural human product is makeable at industrial level. And they are the same.
There's no chemical difference between what gets generated by a white blood cell that has just scooped up a Staphylococcus and what we can make with controlled electrolysis of salt and water.
-- Jeffrey F. Williams, PhD, BVSc, MRCVS, microbiologist and infectious disease expert, has devoted his career to researching, inventing and bringing to market solutions that have improved the lives and health of people all over the world.
-- Professor of Microbiology and Molecular Genetics, Michigan State University (Emeritus)
-- Elected Fellow of the American Association for the Advancement of Science (AAAS)
-- Holder of 30+ patents covering water treatment, disease control, odor control
-- Author of 200+ scientific papers and textbook chapters
-- Member of the Board of Counselors, National Institute of Allergy and Infectious Diseases, National Institute of Health (1984-88)
-- ​Chairman of a World Health Organization research committee on tropical diseases (based in Geneva) (1985-1989)
-- Chief Science Officer, HOCL producer that is world leader in hypochlorous acid technology and manufacturing (2014-2024)
